/ EN
2026-06-27 00:00 United States Papers Foundations & Methods Translated from EN

Nanostructured Coatings on Soft-Polymer Neural Probes for Addressing Neuroinflammation

Summary Researchers transferred dexamethasone-loaded titania nanotube arrays (TNA) onto a mechanically adaptive polymer nanocomposite (NC) substrate and, in a mouse model, compared four implants — silicon, NC, TNA-NC Empty and TNA-NC DEX (10 mice per group) — for neuroinflammation around intracortical microelectrodes at 2 and 4 weeks. At 2 weeks the gene-expression profiles were broadly similar, reflecting an early acute injury response; by 4 weeks the patterns diverged, with NC-based implants showing fewer differentially expressed neuroinflammatory genes than rigid silicon, led by TNA-NC Empty, while the dexamethasone group showed no additional benefit, suggesting drug delivery still needs optimization. The authors conclude that adding a TNA layer to flexible materials promotes resolution of the neuroinflammatory response at 4 weeks.
Why it matters The finding that the plain nanostructured coating outperformed the drug-loaded version complicates the drug-delivery story while reinforcing the material argument: a soft, nanostructured surface may matter more than pharmacology for keeping implanted electrodes viable long-term.

This study, published in Acta Biomaterialia, transferred dexamethasone-loaded titania nanotube arrays (TNAs) onto a mechanically adaptive polymer nanocomposite (NC) substrate and evaluated four implant types (silicon, NC, TNA-NC Empty and TNA-NC DEX; n=10 per group) in a mouse model at 2- and 4-week time points for intracortical microelectrode neuroinflammation.

At 4 weeks, NC-based implants exhibited fewer differentially expressed neuroinflammatory genes relative to rigid silicon implants, with TNA-NC Empty showing the most improvement; the authors conclude that adding the TNA layer to a soft compliant material produces synergistic effects that promote resolution of the neuroinflammatory response at 4 weeks, though dexamethasone delivery still requires optimization. PMID 42361868, DOI 10.1016/j.actbio.2026.06.052

Compiled by BCIwiki from public sources

Sources · 1

From these organizations

2026-08 Case Western Reserve University BCI Society Workshop Tackles Outcome Measures for Pivotal Trials 2026-07 Case Western Reserve University Spatial Proteomic Analysis of Antimicrobial Therapeutic-Releasing Intracortical Probes 2026-07 Case Western Reserve University Ruthenium Oxide Electrode Coating Supports 25 Weeks of Intracortical Stimulation 2026-07 Case Western Reserve University Targeting Grasp-Related Cortical Areas for Intracortical Brain-Machine Interfaces
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About